Pneumococcal Carriage and Disease in Adults in England, 2011-2019: The Importance of Adults as a Reservoir for Pneumococcus in Communities.
El Safadi D. et al, (2025), J Infect Dis, 231, e17 - e27
Essential role of proline synthesis and the one-carbon metabolism pathways for systemic virulence of Streptococcus pneumoniae.
Ramos-Sevillano E. et al, (2024), mBio, 15
Inflammation of the nasal mucosa is associated with susceptibility to experimental pneumococcal challenge in older adults.
Urban BC. et al, (2024), Mucosal Immunol, 17, 973 - 989
RSV and rhinovirus increase pneumococcal carriage acquisition and density, whereas nasal inflammation is associated with bacterial shedding.
Mitsi E. et al, (2024), Cell Host Microbe
Systems Immunology Approaches to Understanding Immune Responses in Acute Infection of Yellow Fever Patients
Gonçalves ANA. et al, (2024)
Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease.
Drury RE. et al, (2024), Nat Commun, 15
Serotype 3 Experimental Human Pneumococcal Challenge (EHPC) study protocol: dose ranging and reproducibility in a healthy volunteer population (challenge 3).
Hazenberg P. et al, (2024), BMJ Open, 14
Experimental pneumococcal carriage in people living with HIV in Malawi: the first controlled human infection model in a key at-risk population
Doherty K. et al, (2024), Wellcome Open Research, 9, 2 - 2
Combinatorial multimer staining and spectral flow cytometry facilitate quantification and characterization of polysaccharide-specific B cell immunity.
Hoving D. et al, (2023), Commun Biol, 6
Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination.
Mitsi E. et al, (2023), Nat Commun, 14
Assessing the use of minimally invasive self-sampling at home for long-term monitoring of the microbiota within UK families.
Nikolaou E. et al, (2023), Sci Rep, 13
Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage of Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a randomised controlled trial and controlled human infection study.
Dula D. et al, (2023), Lancet Microbe, 4, e683 - e691
A Randomised Controlled Trial of Nasal Immunisation with Live Virulence Attenuated Streptococcus pneumoniae Strains Using Human Infection Challenge.
Hill H. et al, (2023), Am J Respir Crit Care Med
Long-term respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination
Mitsi E. et al, (2023)
Long-term respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination
Mitsi E. et al, (2023)